Possible link between toxoplasma gondii and the anosmia associated with neurodegenerative diseases

American Journal of Alzheimer's Disease and other Dementias

Volumn 29, Issue 3, 2014, Pages 205-214

  Prandota, Joseph ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

anosmia; autoimmune diseases; cerebral toxoplasmosis; depression; impaired smell; neurodegeneration; olfaction

Indexed keywords

ANTIDEPRESSANT AGENT; ARACHIDONIC ACID; CHAPERONIN 60; GAMMA INTERFERON; GLUTAMIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANOSMIA; ARTICLE; ASTROCYTE; BEHAVIOR CHANGE; BRAIN CORTEX; CEREBELLUM; DEFENSIVE BEHAVIOR; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DOWN SYNDROME; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; KILLER CELL; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OLFACTORY BULB; OLFACTORY SYSTEM; PARASITE VIRULENCE; SCHIZOPHRENIA; SEXUAL AROUSAL; THALAMUS; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; COMPLICATION; DEPRESSION; IMMUNOLOGY; NEURODEGENERATIVE DISEASES; OLFACTION DISORDERS; PARASITOLOGY;

ANIMALS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; DEPRESSION; HUMANS; NEURODEGENERATIVE DISEASES; OLFACTION DISORDERS; TOXOPLASMOSIS;

EID: 84900387955     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317513517049     Document Type: Article

References (123)

1. Mullol J, Alobid I, Marino-Sanchez F, et al. Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACT study). BMJ Open. 2012 ; 2 (6). e001256
2. Majde JA Neuroinflammation. Pathogenesis, Mechanisms and Management. Gemma C, ed. New York, NY: Nova Science Publishers ; 2012: 237-244.
3. Moscavitch SD, Szyper-Kravitz M, Shoenfeld Y. Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: The olfactory and immune system interrelationship. Clin Immunol. 2009 ; 130 (3). 235-243
4. Prandota J.. Autoimmune hepatitis associated with the odor of fish food proteins. A causal relationship or just a mere association? A case report. Allergol Immunopathol (Madr). 2002 ; 30 (6). 331-337
5. Prandota J. Autoimmune hepatitis and odour of fish food proteins. Allergol Immunopathol (Madr). 2003 ; 31 (1). 56
6. Prandota J. Odour of aquarium fish food proteins as a probable environmental agent causing autoimmune hepatitis in a 15-years-old boy. Pediatr Pol. 2002 ; 77 (4). 337-341
7. Doty RL. Studies of human olfaction from the University of Pennsylvania Smell and Taste Center. Chem Senses. 1997 ; 22 (5). 565-586
8. Majde JA. Neuroinflammation resulting from covert brain invasion by common viruses -A potential role in local and global neurodegeneration. Med Hypotheses. 2010 ; 75 (2). 204-213
9. Mattson MP. Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev. 2004 ; 3 (1). 105-120
10. Perricone C, Shoenfeld N, Agmon-Levin N, et al. Smell and autoimmunity: a comprehensive review. Clinic Rev Allerg Immunol. 2013 ; 45 (1). 87-96
11. Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D, Perry VH. Systemic infection, interleukin 1b, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003 ; 74 (6). 788-789
12. Prandota J. Neuropathological changes and clinical features of autism spectrum disorder participants are similar to that reported in congenital and chronic cerebral toxoplasmosis in humans and mice. Res Autism Spectr Disord. 2010 ; 4 (2). 103-118
13. Prandota J. Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroinflammation causing persistent hypercytokinemia that resulted in an increased lipid peroxidation, oxidative stress, and depressed metabolism of endogenous and exogenous substances. Res Autism Spectr Disord. 2010 ; 4 (2). 119-155
14. Prandota J.. Metabolic, immune, epigenetic, endocrine and phenotypic abnormalities found in individuals with autism spectrum disorders, Down syndrome and Alzheimer disease may be caused by congenital and/or acquired chronic cerebral toxoplasmosis. Res Autism Spectr Disord. 2011 ; 5 (1). 14-59
15. Klaren VN, Kijstra A. Toxoplasmosis, an overview with emphasis on ocular involvement. Ocul Immunol Inflamm. 2002 ; 10 (1). 1-26
16. Furtado JM, Smith JR, Belfort R, Gattey D, Winthrop KL. Toxoplasmosis: a global threat. J Glob Infect Dis. 2011 ; 3 (3). 281-284
17. Carter CJ. Toxoplasmosis and polygenic disease susceptibility genes: extensive Toxoplasma gondii host/pathogen interactome enrichment in nine psychiatric or neurological disorders. J Pathog. 2013 ; ( 2013 ):
18. Halonen SK, Weiss LM. Toxoplasmosis. Neuroparasitology and Tropical Neurology, Handbook of Clinical Neurology Series. 2013 ;: 125-145
19. McLeod R, Van Tubbergen C, Montoya JG, Petersen E Toxoplasma Gondii. 2 nd ed. Amsterdam, Netherlands: Academic Press; 2014:99-159. Weiss LM Kim K, ed. Amsterdam, Netherlands: Academic Press ; 2014: 99-159.
20. Torgerson R, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013 ; 91 (7). 501-508
21. Nissapatorn V. Toxoplasmosis: a silent threat in Southeast Asia. J Parasitol. 2007 ; 2 (1). 1-12
22. FlegrJPrandotaJSovi kováMIsrailiZH. Toxoplasmosis-A global threat. Correlation between latent toxoplasmosis and specific disease burden-a WHO data-based study of 29 European and 59 non-European countries. (2013). Manuscript sent for publication.
23. Elsheikha HM. Congenital toxoplasmosis: priorities for further health promotion action. Public Health. 2008 ; 122 (4). 335-353
24. Nowakowska D, Wujcicka W, Sobala W, Spiewak E, Gaj Z, Wilczyski J. Age-associated prevalence of Toxoplasma gondii in 8281 pregnant women in Poland between 2004 and 2012. Epidemiol Infect. 2013 ; 31: 1-6
25. Hoffman HJ, Ishill EK, Macturk RH. Age-related changes in the prevalence of smell/taste problems among the United States adult population. Ann NY Acad Sci. 1998 ; 855 (1). 716-722
26. Karstensen HG, Tommerup N. Isolated and syndromic forms of congenital anosmia. Clin Genet. 2012 ; 81 (3). 210-215
27. Barresi M, Ciurleo R, Giacoppo S, et al. Evaluation of olfactory dysfunction in neurodegenerative diseases. J Neurol Sci. 2012 ; 323 (1-2). 16-24
28. Frasnelli J, Fark T, Lehmann J, Gerber J, Hummel T. Brain structure is changed in congenital ansomia. NeuroImage. 2013 ; 83: 1074-1080
29. Fond G, Capdevielle D, Macgregor A, et al. Toxoplasma gondii: a potential role in the genesis of psychiatric disorders [in French]. Encephale. 2013 ; 39 (1). 38-43
30. Conley FK, Jenkins KA. Immunohistological study of the anatomic relationship of Toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii. Infect Immun. 1981 ; 31 (3). 1184-1192
31. Haroon F, Händel U, Angenstein F, et al. Toxoplasma gondii actively inhibits neuronal function in chronically infected mice. PLoS One. 2012 ; 7 (4). e35516
32. Berenreiterova M, Flegr J, Kubena AA, Nemec P. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis. Implications of the behavioral manipulation hypothesis. PLoS One. 2011 ; 6 (12). e28925
33. Melzer TC, Cranston HJ, Weiss LM, Halonen SK. Host cell preference of Toxoplasma gondii cysts in murine brain: a confocal study. J Neuroparasitol. 2010 ;: 1
34. Ferguson DJ, Hutchison WM. An ultrastructural study of the early development and tissue cyst formation of Toxoplasma gondii in the brains of mice. Parasitol Res. 1987 ; 73 (6). 483-491
35. Dellacasa-Lindberg I, Fuks JM, Arrighi RB, et al. Migratory activation of primary cortical microglia upon infection with Toxoplasma gondii. Infect Immun. 2011 ; 79 (8). 046-3052
36. Wang T, Liu M, Gao XJ, Zhao ZJ, Chen XG, Lun ZR. Toxoplasma gondii: the effects of infection at different stages of pregnancy on the offspring of mice. Exp Parasitol. 2011 ; 127 (1). 107-112
37. Lüder CG, Giraldo-Velasquez M, Sendtner M, Gross U. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp Parasitol. 1999 ; 93 (1). 23-32
38. Fagard R, Van Tan H, Creuzet C, Pelloux H. Differential development of Toxoplasma gondii in neural cells. Parasitol Today. 1999 ; 15 (12). 504-507
39. Chao CC, Anderson WR, Hu S, Gekker G, Martella A, Peterson PK. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin Immunol Immunopathol. 1993 ; 67 (2). 178-183
40. Peterson PK, Gekker G, Hu S, Chao CC. Intracellular survival and multiplication of Toxoplasma gondii in astrocytes. J Infect Dis. 1 993 ; 168 (6). 1472-1478
41. Creuzet C, Robert F, Roisin MP, et al. Neurons in primary culture are less efficiently infected by Toxoplasma gondii than glial cells. Parasitol Res. 1998 ; 84 (1). 25-30
42. Halonen SK, Lyman WD, Chiu FC. Growth and development of Toxoplasma gondii in human neurons and astrocytes. J Neuropathol Exp Neurosci. 1996 ; 55 (11). 1150-1156
43. Jones TC, Bienz KA, Erb P. In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of gamma interferon. Infect Immun. 1986 ; 51 (1). 147-156
44. Fischer HG, Nitzgen B, Reichmann G, Gross U, Hadding U. Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol Res. 1997 ; 83: 637-641
45. Fischer HG, Nitzgen B, Reichmann G, Hadding U. Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. Eur J Immunol. 1997 ; 27 (6). 1539-1548
46. Däubener W, Remscheid C, Nockemann S, et al. Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis-alpha. Eur J Immunol. 1996 ; 26 (2). 487-492
47. Minc-Golomb D, Tsarfaty I, Schwartz JP. Expression of inducible nitric oxide synthase by neurons following exposure to endotoxin and cytokine. Brit J Pharmacol. 1994 ; 112 (3). 720-722
48. Minamitani M, Tanaka J, Suzuki Y. Pathomechanism of cerebral hypoplasia in experimental toxoplasmosis in murine fetuses. Early Human Dev. 1996 ; 44 (1). 37-50
49. Shibata H, Katsuki H, Nishiwaki M, Kume T, Kaneko S, Akaike A. Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice culture: role of inducible nitric oxide synthase and protection by indomethacin. J Neurochem. 2003 ; 86 (5). 1201-1212
50. Castano A, Herrera AJ, Cano J, Machado A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem. 1998 ; 70 (4). 1584-1592
51. Herrera AJ, Castano A, Venero JL, Cano J, Machado A. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis. 2000 ; 7 (4). 429-447
52. Lee P, Son D, Lee J, Kim YS, Kim H, Kim SY. Excessive production of nitric oxide induces the neuronal cell death in lipopolysaccharide-treated rat hippocampal slice culture. Neurosci Lett. 2003 ; 349 (1). 33-36
53. Picot L, Chevalier S, Mezghani-Abdelmoula S, et al. Cytotoxic effects of the lipopolysaccharide from Pseudomonas fluorescence on neurons and glial cells. Microb Pathog. 2003 ; 35 (3). 95-106
54. Arciszewski M, Pierzynowski S, Ekbald E. Lipopolysaccharide induces cell death in cultured porcine myenteric neurons. Dig Dis Sci. 2005 ; 50 (9). 1661-1668
55. Prandota J. Gastrointestinal tract abnormalities in autism, inflammatory bowel disease and many other clinical entities may be due to T. gondii infection. Sci Rep. 2012 ; 1: 4
56. Butcher BA, Kim L, Johnson PF, Denkers EY. Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-kappa B. J Immunol. 2001 ; 167 (4). 193-2201
57. Suzuki Y. Immunopathogenesis of cerebral toxoplasmosis. J Infect Dis. 2002 ; 186 (suppl 2). S234 - S240
58. Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One. 2011 ; 6 (9). e23866
59. Stibbs HH. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol. 1985 ; 79 (2). 153-157
60. Silva NM, Rodrigues CV, Santoro MM, Reis LFL, Alvarez-Leite JI, Gazzinelli RT. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation and kynurenine formation during in vivo infection with Toxoplasma gondii: induction of endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect Immun. 2002 ; 70 (2). 859-868
61. Strobl JS, Goodwin DG, Rzigalinski BA, Lindsay DS. Dopamine stimulates propagation of Toxoplasma gondii tachyzoites in human fibroblast and primary neonatal rat astrocyte cell cultures. J Parasitol. 2012 ; 98 (6). 1296-1298
62. Pollak Y, Yirmiya R. Cytokine-induced changes in mood and behavior: implications for depression due to a general medical condition, immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol. 2002 ; 5 (4). 389-399
63. Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: what can we learn from animal studies?. Neurosci Biobehav Rev. 2005 ; 29 (4-5). 891-909
64. Dudova I, Vodicka J, Havlovicova M, Sedlacek Z, Urbanek T, Hrdlicka M. Odor detection threshold, but not odor identification, is impaired in children with autism. Eur Child Adolesc Psychiatry. 2011 ; 20 (7). 333-340
65. Suzuki Y, Critchley HD, Rowe A, Howlin P, Murphy DG. Impaired olfactory identification in Asperger's syndrome. J Neuropsychiatry Clin Neurosci. 2003 ; 15 (1). 105-107
66. Sjöstrand C, Savic I, Laudon-Meyer E, Hillert L, Lodin K, Waldenlind E. Migraine and olfactory stimuli. Curr Pain Headache Rep. 2010 ; 14 (3). 244-251
67. Prandota J.. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy. The parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches. Am J Ther. 2007 ; 14 (1). 63-105
68. Schubert CR, Cruickshanks KJ, Murphy C, et al. Olfactory impairment in adults: the beaver dam experience. Ann NY Acad Sci. 2009 ; 1170: 531-536
69. Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA. 2002 ; 288 (18). 2307-2312
70. Hinze-Selch D, Däubener W, Erdag S, Wilms S. The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol (Praha). 2010 ; 57 (2). 129-135
71. Rea IM, McNerlan S, Pockley AG. Serum heat shock protein and anti-heat shock protein antibody levels in aging. Exp Gerontol. 2001 ; 36 (2). 341-352
72. Hisaeda H, Himeno K. The role of host-derived heat shock protein in immunity against Toxoplasma gondii infection. Parasitol Today. 1997 ; 13 (12). 465-468
73. Araujo FG, Slifer T. Different strains of Toxoplasma gondii induce different cytokine responses in CBA/Ca mice. Infect Immun. 2003 ; 71 (7). 4171-4174
74. Tait ED, Jordan KA, Dupont CD, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010 ; 185 (3). 1502-1512
75. Zaniolo LM, da Silva AV, Sant'Ana Dde M, Araújo EJ. Toxoplasma gondii infection causes morphological changes in caecal myenteric neurons. Exp Parasitol. 2012 ; 130 (2). 103-109
76. Silva LS, Sartori AL, Zaniolo LM, da Silva AV, Sant'Ana Dde M, Araújo EJ. Toxoplasma gondii: myenteric neurons of intraperitoneally inoculated rats show quantitative and morphometric alterations. Exp Parasitol. 2011 ; 129 (1). 5-10
77. Odorizzi L, Moreira NM, Gonçalves GF, da Silva AV, Sant'ana Dde M, Araújo EJ. Quantitative and morphometric changes of subpopulations of myenteric neurons in swines with toxoplasmosis. Auton Neurosci. 2010 ; 155 (1-2). 68-72
78. Cabarrocas J, Savidge TC, Liblau RS. Role of enteric glial cells in inflammatory bowel disease. Glia. 2003 ; 41 (1). 81-93
79. Xiao J, Kannan G, Jones-Brando L, et al. Sex-specific changes in gene expression and behavior induced by chronic Toxoplasma infection in mice. Neuroscience. 2012 ; 206: 39-48
80. House PK, Vyas A, Sapolsky R. Predator cat odors activate sexual arousal pathways in brains of Toxoplasma gondii infected rats. PLoS One. 2011 ; 6 (8). e23277
81. VosHR HerrlingerR (1964) Taschenbuch der Anatomie. PZWL, Warsaw 1974, part III, p. 50.
82. Vyas A, Kim SK, Sapolsky R. The effects of toxoplasma infection on rodent behavior are dependent on dose of the stimulus. Neuroscience. 2007 ; 148 (2). 342-348
83. Turetsky BI, Moberg PJ, Arnold SE, Doty RL, Gur RE. Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am J Psychiatry. 2003 ; 160 (4). 703-708
84. Appenzeller S, Carnewalle AD, Li LM, Constallat LT, Cendes F. Hippocampal atrophy in systemic lupus erythematosus. Ann Rheum. 2006 ; 65 (12). 1585-1589
85. Emmer BJ, van der Grond J, Steup-Beekman GM, Huizinga TWJ, van Buchem MA. Selective involvement of the amygdala in systemic lupus erythematosus. PLoS Med. 2006 ; 3 (12). e499
86. Haehner A, Boesveldt S, Berendse HW, et al. Prevalence of smell loss in Parkinson's disease - a multicenter study. Parkinsonism Relat Disord. 2009 ; 15 (7). 490-494
87. Murakami T, Nakajima M, Nakamura T, et al. Parkinsonian symptoms as an initial manifestation in a Japanese patient with acquired immunodeficiency syndrome and Toxoplasma infection. Internal Med. 2000 ; 39 (12). 1111-1114
88. Graham CS, Graham BG, Bartlett JA, Heald AE, Schiffman SS. Taste and smell losses in HIV infected patients. Physiol Behav. 1995 ; 58 (2). 287-293
89. Zucco GM, Ingegneri G. Olfactory deficits in HIV-infected patients with and without AIDS dementia complex. Physiol Behav. 2004 ; 80 (5). 669-674
90. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol. 1998 ; 55 (1). 84-90
91. Murphy C, Jinich S. Olfactory dysfunction in Down's syndrome. Neurobiol Aging. 1996 ; 7 (4). 631-637
92. Zivadinov R, Zorzon M, Monti Bragadin L, Pagliaro G, Cazzato G. Olfactory loss in multiple sclerosis. J Neurol Sci. 1999 ; 168 (2). 127-130
93. Stojanovich L, Zandman-Goddard G, Pavlovich S, Sikanich N. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev. 2007 ; 6 (6). 421-426
94. Moberg PJ, Doty RL, Turetsky BI, et al. Olfactory identification deficits in schizophrenia: correlation with duration of illness. Am J Psychiatry. 1997 ; 154 (7). 1016-1018
95. Kopala LC, Good KP, Morrison K, Bassett AS, Alda M, Honer WG. Impaired olfactory identification in relatives of patients with familial schizophrenia. Am J Psychiatry. 2001 ; 158 (8). 1286-1290
96. Wohlgemuth C, Beinder E, Ochsenbein-Kölbie N, Hummel T. Changes in olfactory function with several pregnancies?. Swiss Med Wkly. 2008 ; 138 (31-32). 466-469
97. Kusbeci OY, Miman O, Yaman N, Aktepe OC, Yazar S. Could Toxoplasma gondii have any role in Alzheimer's disease. Alzheimer Dis Assoc Disord. 2011 ; 25 (1). 1-3
98. Miman O, Kusbeci OY, Aktepe OC, Cetinkaya Z. The probable relation between Toxoplasma gondii and Parkinson's disease. Neurosci Lett. 2010 ; 475 (3). 129-131
99. Koseoglu E, Yazar S, Koc I. Is Toxoplasma gondii a causal agent in migraine?. Am J Med Sci. 2009 ; 338 (2). 120-122
100. Emelia O, Amal RN, Ruzanna ZZ, et al. Seroprevalence of anti-Toxoplasma gondii IgG antibody in patients with schizophrenia. Trop Biomed. 2012 ; 29 (1). 151-159
101. Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: A meta-analysis. Schizophr Bull. 2007 ; 33 (3). 729-736
102. Oksenhendler E, Charreau I, Tournerie C, Mahamoudu A, Carbon C, Aboulker JP. Toxoplasma gondii infection in advanced HIV infection. AIDS. 1994 ; 8 (4). 483-487
103. Arnson Y, Amital H, Guiducci S, et al. The role of infections in the immunopathogenesis of systemic sclerosis - evidence from serological studies. Ann NY Acad Sci. 2009 ; 1173: 627-632
104. Wilcox MH, Powell RJ, Pugh SF, Balfour AH. Toxoplasmosis and systemic lupus erythematosus. Ann Rheum Dis. 1990 ; 49 (4). 254-257
105. Gröer MW, Yolken RH, Xiao JC, et al. Prenatal depression and anxiety in Toxoplasma gondii-positive women. Am J Obst Gynecol. 2011 ; 204 (5). e1 - e7
106. Radford A, Williams SN, Kane B, Groer M. Relationship of Toxoplasma gondii antibody titers and dysphoric moods in female veterans [abstract]. Brain Behav Immun. 2012 ; 26 (Suppl 1). S23
107. Penninx BW, Kritchevsky SB, Yaffe K, et al. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry. 2003 ; 54 (5). 566-572
108. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry. 2002 ; 159 (11). 1862-1868
109. Beiske AG, Svensson E, Sandanger I, et al. Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol. 2008 ; 15 (3). 239-245
110. Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord. 2003 ; 18 (4). 414-418
111. Song C, Leonard BE. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev. 2005 ; 29 (4-5). 627-647
112. Diaconu G, Turecki G. Obsessive-compulsive personality disorder and suicidal behavior: evidence for a positive association in a sample of depressed patients. J Clin Psychiatry. 2009 ; 70 (11). 1551-1556
113. Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S. Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder?. Psychiatry Res. 2010 ; 177 (1-2). 263-265
114. Arling TA, Yolken RH, Lapidus M, et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis. 2009 ; 197 (12). 905-908
115. Antonioli M, Rybka J, Carvalho LA. Neuroimmune endocrine effects of antidepressants. Neuropsychiatr Dis Treat. 2012 ; 8: 65-83
116. Webster JP, McConkey GA. Toxoplasma gondii-altered host behavior: clues as to mechanism of action. Folia Parasitol. 2010 ; 57 (2). 95-104
117. Kannan G, Moldovan K, Xiao JC, Yolken RH, Jones-Brando L, Pletnikov MV. Parasite strain-dependent effects of Toxoplasma gondii on mouse behaviour. Folia Parasitol (Praha). 2010 ; 57 (2). 151-155
118. Bonenfant C, Dimier-Poisson I, Velge-Roussel F, et al. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii. Infect Immun. 2001 ; 69 (3). 1605-1612
119. Suzuki Y, Yang Q, Conley FK, Abrams JS, Remington JS. Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis. Infect Immun. 1994 ; 62 (7). 2773-2778
120. Beaman MH, Hunter CA, Remington JS. Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNF-alpha. J Immunol. 1994 ; 153 (10). 4583-4587
121. Prandota J Neuroinflammation. Pathogenesis, Mechanisms, and Management. Gemma C, ed. New York, NY: Nova Science Publishers ; 2012: 447-638.
122. Holec-Gasior L.. Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis. Current status of studies. Clin Vac Immunol. 2013 ; 20 (9). 1343-1351
123. Western blotting for the diagnosis of congenital toxoplasmosis